Upload Avatar (500 x 500)
Hui Wang
wanghui19@whu.edu.cn
Chinese
Hubei
Wuhan University
Basic Medical Sciences
  • 2004.4 - 2004.7: Studied at National Education Administration College
  • 1996.9 - 1999.6: PhD in Hepatic Pharmacology, Hubei Medical University
  • 1988.9 - 1991.7: Master's in Pharmacology, Hubei Medical University
  • 1981.9 - 1986.7: Bachelor of Medicine, Hubei Medical College
  • 2012.12 - 2022.8: Second-level Professor, Doctoral Supervisor, Director of Provincial Key Laboratory, Department of Pharmacology, School of Basic Medical Sciences, Wuhan University
  • 2000.4 - 2012.12: Professor, Doctoral Supervisor, Deputy Dean, Department of Pharmacology, School of Basic Medical Sciences, Wuhan University
  • 1997.1 - 2000.3: Associate Professor, Department of Pharmacology, Hubei Medical University
  • 1993.6 - 1996.12: Lecturer, Department of Pharmacology, Hubei Medical University
  • 1991.6 - 1993.5: Assistant, Department of Pharmacology, Hubei Medical University
  • 1986.7 - 1988.8: Resident Physician, Third Hospital of Wuhan
  • 2019: Second Hubei Medical Leadership Talent Engineering Trainee and Hubei Famous Doctor Studio Head
  • 2017: Wuhan University Teaching Master
  • 2016: Luojia Outstanding Scholar of Wuhan University (re-awarded)
  • 2016: Hubei Provincial Government Special Allowance
  • 2014: Wuhan University President's Award for Outstanding Teaching Contribution
  • 2014: Zhu Yubi Medical Prize of Wuhan University Medical Department
  • 2013: Luojia Outstanding Scholar of Wuhan University
  • 2013: Top Ten Moral Models of Wuhan University
  • 2012: My Favorite Excellent Teacher Award of Wuhan University
  • 2005: Wuhan City Science and Technology Rising Star
  • 2001: Wuhan City Government Talent Special Allowance
  • 2001: Baosteel Education Fund National Outstanding Teacher Award
  • 2000: Servier National Young Pharmacologist Honor Title by the Chinese Pharmacological Society
  • 1999: Hubei Provincial Higher Education Scientific Innovation and Achievement Transformation Promotion Award
  • 1998: Third Prize in the Sixth National Young Teacher Award of the Fok Ying Tung Education Foundation
Drug targets and new drug development
Xenobiotic developmental toxicology
  • Metal-Drug Nanoparticles-Mediated Osteolytic Microenvironment Regulation for Enhanced Radiotherapy of Orthotopic Osteosarcoma, Geng H, Zhou MX, Li B, Liu L, Yang X, Wen YX, Yu HJ, Wang H*, Chen J*, Chen LB*, 2021
  • Developmental toxicity and programming alterations of multiple organs in offspring induced by medication during pregnancy, Lu ZJ, Guo Y, Xu D, Xiao H, Kou H, Ao Y, Liu KX, Chen LB*, Wang H*, 2022
  • Hyperglycemia-induced accumulation of advanced glycosylation end products in fibroblast-like synoviocytes promotes knee osteoarthritis, Li QX, Wen YX, Wang LL, Chen B, Chen J, Wang H*, Chen LB*, 2021
  • P-gp expression inhibition mediates placental glucocorticoid barrier opening and fetal weight loss, Ge CY, Xu D, Yu PX, Fang M, Guo JJ, Xu D, Qiao Y, Chen SJ, Zhang YZ*, Wang H*, 2021
  • Dexamethasone induces an imbalanced fetal-placental-maternal bile acid circulation: Involvement of placental transporters, Huang W, Zhou J, Guo JJ, Hu W, Chen GH, Li B, Wen YJ, Jiang YM, Fu KL, Bi HC*, Zhang YZ*, Wang H*, 2021
  • Prenatal dexamethasone exposure induced pancreatic β-cell dysfunction and glucose intolerance of male offspring rats: Role of the epigenetic repression of ACE2, Dai Y, Kou H, Gui S, Guo X, Liu H, Gong Z, Sun X, Wang H*, Guo Y*, 2022
  • Differential expression of placental 11β-HSD2 induced by high maternal glucocorticoid exposure mediates sex differences in placental and fetal development, Yu P, Zhou J, Ge C, Fang M, Zhang Y, Wang H*, 2022
  • Maternally derived low glucocorticoid mediates adrenal developmental programming alteration in offspring induced by dexamethasone, Chen YW, Xia X, Fang M, Chen GH, Cao JG, Qu H, Wang H*, 2021
  • H19/let-7 axis mediates caffeine exposure during pregnancy induced adrenal dysfunction and its multi-generation inheritance, He Z, Zhang JZ, Chen GH, Cao JG, Chen YW, Ai C, Wang H*, 2021
  • Intrauterine endogenous high glucocorticoids program ovarian dysfunction in female offspring secondary to prenatal caffeine exposure, Lv F, Fan GL, Wan Y, Chen YX, Ni Y, Huang J, Xu D, Zhang W*, Wang H*, 2021
  • 11β-Hydroxysteroid dehydrogenase 2: A key mediator of high susceptibility to osteoporosis in offspring after prenatal dexamethasone exposure, Wu Z, Wen Y, Xiao H, Zhu J, Li B, Shangguan Y, He H, Wang H*, Chen L*, 2022
  • miRNA320a-3p/RUNX2 signal programming mediates the transgenerational inheritance of inhibited ovarian estrogen synthesis in female offspring rats induced by prenatal dexamethasone exposure, Gong XH, Zhang JZ, Ge CY, Yi YW, Dai SY, Fan GL, Zhang YZ, Wang H*, Xu D*, 2021
  • Sex difference in adrenal developmental toxicity induced by dexamethasone and its intrauterine programming mechanism, Chen YW, Xu D, Xia X, Chen GH, Xiao H, Chen LB*, Wang H*, 2021
  • Programming changes in GLUT1 mediated the accumulation of AGEs and matrix degradation in the articular cartilage of female adult rats after prenatal caffeine exposure, Li QX, Wang LL, Wang YZ, Liu L, Han H, Chen LB*, Wang H*, 2020
  • The low-expression programming of 11β-HSD2 mediates osteoporosis susceptibility induced by prenatal caffeine exposure in male offspring rats, Xiao H, Wu ZX, Li B, Shangguan YF, Jean-François Stoltz, Jacques Magdalou, Chen LB *, Wang H*, 2020
Drug Targets New Drug Development Xenobiotics Developmental Toxicology Drug Research Toxicology Pharmacology Drug Safety Drug Efficacy Medical Research

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.